[Electroencephalographic study of maprotiline, a new antidepressive agent].
D000161:Acoustic Stimulation; D000639:Amitriptyline / Q000494:pharmacology; D000679:Amygdala / Q000187:drug effects; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D008376:Maprotiline / Q000494:pharmacology*; D008636:Mesencephalon / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D011817:Rabbits; D012154:Reticular Formation / Q000187:drug effects; D013787:Thalamic Nuclei / Q000187:drug effects; D013826:Theta Rhythm
D000873:Anthracenes; D000928:Antidepressive Agents; D000639:Amitriptyline; D008376:Maprotiline; D010830:Physostigmine; D007099:Imipramine; D002746:Chlorpromazine